Apeiron’s Christian Angermayer on using psychedelic drugs for mental health treatment
Christian Angermayer, Apeiron Investment Group founder, joins ‘Squawk Box’ to discuss President Trump’s executive order directing government agencies to accelerate psychedelic treatments for serious mental illness, investor appetite for psychedelics, and more.
